Logo image of CHSN

CHANSON INTERNATIONAL HOLD-A (CHSN) Stock Fundamental Analysis

USA - NASDAQ:CHSN - KYG2104U2066 - Common Stock

2.42 USD
-0.07 (-2.81%)
Last: 10/17/2025, 8:02:31 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHSN. CHSN was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. CHSN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CHSN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CHSN has reported negative net income.
In the past year CHSN had a positive cash flow from operations.
In multiple years CHSN reported negative net income over the last 5 years.
Of the past 5 years CHSN 4 years had a positive operating cash flow.
CHSN Yearly Net Income VS EBIT VS OCF VS FCFCHSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

The Return On Assets of CHSN (-0.61%) is worse than 66.67% of its industry peers.
CHSN's Return On Equity of -1.29% is on the low side compared to the rest of the industry. CHSN is outperformed by 64.10% of its industry peers.
Industry RankSector Rank
ROA -0.61%
ROE -1.29%
ROIC N/A
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
CHSN Yearly ROA, ROE, ROICCHSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of CHSN has declined.
CHSN has a Gross Margin of 40.95%. This is amongst the best in the industry. CHSN outperforms 89.74% of its industry peers.
In the last couple of years the Gross Margin of CHSN has declined.
The Profit Margin and Operating Margin are not available for CHSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
CHSN Yearly Profit, Operating, Gross MarginsCHSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

6

2. Health

2.1 Basic Checks

CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHSN has been reduced compared to 1 year ago.
The number of shares outstanding for CHSN has been reduced compared to 5 years ago.
Compared to 1 year ago, CHSN has an improved debt to assets ratio.
CHSN Yearly Shares OutstandingCHSN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CHSN Yearly Total Debt VS Total AssetsCHSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.68, we must say that CHSN is in the distress zone and has some risk of bankruptcy.
CHSN has a Altman-Z score of 0.68. This is amonst the worse of the industry: CHSN underperforms 87.18% of its industry peers.
CHSN has a debt to FCF ratio of 3.29. This is a good value and a sign of high solvency as CHSN would need 3.29 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.29, CHSN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that CHSN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.19, CHSN is doing good in the industry, outperforming 74.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 3.29
Altman-Z 0.68
ROIC/WACCN/A
WACC6.82%
CHSN Yearly LT Debt VS Equity VS FCFCHSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.00 indicates that CHSN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.00, CHSN belongs to the top of the industry, outperforming 82.05% of the companies in the same industry.
CHSN has a Quick Ratio of 1.95. This is a normal value and indicates that CHSN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.95, CHSN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.95
CHSN Yearly Current Assets VS Current LiabilitesCHSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.11% over the past year.
CHSN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.68% yearly.
Looking at the last year, CHSN shows a very strong growth in Revenue. The Revenue has grown by 21.20%.
CHSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.70% yearly.
EPS 1Y (TTM)100.11%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%-2003.98%
Revenue 1Y (TTM)21.2%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%15.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSN Yearly Revenue VS EstimatesCHSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSN Price Earnings VS Forward Price EarningsCHSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

97.44% of the companies in the same industry are more expensive than CHSN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.86
EV/EBITDA N/A
CHSN Per share dataCHSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHSN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (10/17/2025, 8:02:31 PM)

2.42

-0.07 (-2.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.6%
Inst Owner ChangeN/A
Ins Owners8.55%
Ins Owner ChangeN/A
Market Cap2.76M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF 1.86
P/OCF 1.18
P/B 0.11
P/tB 0.11
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.3
FCFY53.72%
OCF(TTM)2.05
OCFY84.88%
SpS16.99
BVpS21.53
TBVpS21.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -1.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.95%
FCFM 7.65%
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 3.29
Debt/EBITDA N/A
Cap/Depr 111.45%
Cap/Sales 4.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.95
Altman-Z 0.68
F-Score3
WACC6.82%
ROIC/WACCN/A
Cap/Depr(3y)101.58%
Cap/Depr(5y)151.1%
Cap/Sales(3y)5.01%
Cap/Sales(5y)6.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.11%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%-2003.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.2%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%15.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.23%
FCF growth 3YN/A
FCF growth 5Y30.19%
OCF growth 1Y54.05%
OCF growth 3Y25.73%
OCF growth 5Y19.86%